CD79B and diffuse large B-cell lymphoma: In ~20% of ABC-DLBCL (50% of MCD/C5-DLBCL), gain-of-function mutations in the gene encoding CD79B target the protein immunoreceptor tyrosine-based activation motifs (ITAMs), thus abrogating a negative feedback loop mediated by the Lyn kinase [98].